Clinical Trials Browser

Phase 1 × Not yet recruiting × irinotecan sucrosofate × Clear all

NCT07060014 2025-07-11

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

Phase 1 Not yet recruiting

Gastrointestinal

Advanced Small Intestine Cancer

NCT06710821 2024-11-29

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer